
This study looks at the risk of adverse events following immunization by comparing the safety profile of the mRNA COVID-19 vaccines to the safety profile of the influenza vaccines.

This study looks at the risk of adverse events following immunization by comparing the safety profile of the mRNA COVID-19 vaccines to the safety profile of the influenza vaccines.

By identifying 22 key parameters in study designs, investigators hope to establish a standardized approach for analyzing moderate-to-severe atopic dermatitis trial results.

Sulfonylurea and/or insulin deintensification occurred in fewer than 50% of older adults with diabetes within 100 days of a hypoglycemia-associated ED visit.

Between 2011-2018, hospital admissions for CDI has decreased dramatically.

Proportion of eyes with IOP-related events supported monitoring in eyes treated with anti-VEGF therapy for macular edema associated with CRVO or HRVO for up to 60 months.

Investigators reported that patients in the vitiligo group reported worse general health, and were willing to pay more than 40% of their income for a cure.

Phase 3 data show the solution works as fast 15 minutes and lasts for up to 6 hours, to improve near vision without impacting distance vision.

Incidence rates of post-Ad26.COV2.S vaccination cerebral venous sinus thrombosis was 8.65 per 100,000 person-years.

Investigators noted the treatment method was well tolerated in patients who could not safely use oral cyclosporine.

A combination of poor performance and methodological limitations were found for the machine learning models.

Patients with the absence of urgency had significantly greater reductions in levels of inflammatory biomarkers C-reactive protein and fecal calprotectin in a cohort of patients treated with mirikizumab.

ACG represents the first major in-person conference since the COVID-19 pandemic.

Hospital systems were able to effectively mitigate challenges during COVID-19, with 24-hour time-to-surgery benchmarks unchanged from before to after the pandemic.

Even though COVID-19 infection disproportionately impacts minority patients, there’s no indication that vaccine intention differs depending on race in IBD patients.

Investigators believe that goal-oriented care is possible with additional lifestyle medicine training for physiatrists.

Investigators stated that prolonged maintenance dosing of the monoclonal antibody was preferred by affected patients.

Investigators reported that the efficacy of the medication is supported by a high safety profile, with fleeting and limited adverse events recorded.

This study found that compared with the general population, the prevalence of celiac disease in people with type 1 diabetes mellitus is increased.

The American College of Cardiology and American Heart Association guideline provides key highlights into the evaluation and diagnosis of adult patients with chest pain.

Dr. Feuerstadt presented data about RBX2660 during the recent ACG 2021 meeting.

Approximately 50% of children with laboratory-confirmed influenza in 2015 - 2016 were treated with antivirals, despite recommendations on their use.

A cross-sectional analysis suggests children aged 5-7 years old may begin to reckon with the burdens of sickle cell disease, while toddlers and infants may not.

Hospitalized patients were more likely to have impairments in attention, executive functioning, and category fluency compared to those in the outpatient group.

Investigators suggested the prevention of exposure during pregnancy could help control atopic dermatitis and other potential allergies in pediatric populations.


In all visits, data show 23.8% were virtual, 8.2% were in-person at home, and 68.0% were in-person and onsite.

Data show nonfatal MI did not meet the threshold for surrogacy for all-cause mortality or CV mortality.

In his lecture, The End of the Beginning: Megatrends in Gastroenterology, William Chey, MD, emphasizes the importance of a multidisciplinary integrated care approach to treating IBS.

An absence of urgency was associated with greater reductions in levels of inflammatory biomarkers C-reactive protein and fecal calprotectin in a cohort of patients treated with mirikizumab.

Approximately 88% of patients treated with SER-109 achieved a sustained clinical response at 8 weeks.